NCT06572423 - Personalized Ultrafractionated Stereotactic Adaptive Radiotherapy for Palliative Head and Neck Cancer Treatment (PULS-Pal) | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

October 25, 2024

Primary Completion Date

December 16, 2028

Study Completion Date

December 16, 2029

Conditions

Head and Neck CarcinomaLocalized Head and Neck CarcinomaMetastatic Head and Neck CarcinomaRecurrent Head and Neck Carcinoma

Interventions

PROCEDURE

Personalized ultrafractionated stereotactic adaptive radiotherapy

PULSAR is a radiation therapy regimen that uses a limited number of fairly large dose pulses while adjusting to specific anatomic and/or biological changes which may occur during the course of the treatment.

RADIATION

Volume Modulated Arc Therapy

Use HyperArc technology

PROCEDURE

Computed Tomography

Undergo CT simulation for radiation planning

PROCEDURE

Positron Emission Tomography

Undergo PET

PROCEDURE

Magnetic Resonance Imaging

Undergo MRI

OTHER

Best Practice

Undergo standard of care

BEHAVIORAL

University of Washington Quality of Life Scale, Version 4

Complete questionnaire

BEHAVIORAL

Functional Assessment of Cancer Therapy-Head & Neck

Complete questionnaire

Trial Locations (1)

90095

RECRUITING

University of California at Los Angeles, Los Angeles